Search

everythinglearnresearchcommunity

for

Search:↓

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

Corkscrew hairs can help diagnose trichotillomania.

Gap junctions help control feather pattern formation in chickens.

Computational techniques can improve drug development for treating certain conditions.

The DLQI is reliable but may not fully capture the impact of skin conditions on quality of life, especially in emotional and psychological areas.

A new microneedle patch helps treat hair loss by improving drug delivery to hair follicles.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

Accurate diagnosis is crucial for effective treatment of hair loss.

Chemotherapy with docetaxel and cisplatin can cause severe low potassium, requiring careful monitoring and treatment.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Quercetin-loaded nanoparticles can penetrate skin, minimize hair loss, and promote hair regrowth, showing slightly better results than a marketed product.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Prompt treatment of tinea capitis with oral antifungals leads to excellent recovery, but delayed care can cause permanent hair loss.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Mefloquine, an antimalarial drug, is effective in killing melanoma cells resistant to other treatments by causing lethal stress in the cells.

The mTurq2-Col4a1 mouse model shows that cells can divide while attached to stable basement membranes during development.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

D-OCT shows increased blood vessel growth in response to tissue damage in Frontal Fibrosing Alopecia and is useful for diagnosis and monitoring.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

Ritlecitinib improves hair regrowth in alopecia areata over 24 months.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

The document concludes that stem cell inactivity is actively controlled and important for tissue repair and balance.

Low zinc and copper levels may indicate Telogen Effluvium.

Ritlecitinib is an effective new treatment for Alopecia Areata.

QSOX enzymes help form protein bonds in cells, especially in tissues with high secretory activity.

Ritlecitinib is effective for long-term hair regrowth in alopecia areata, especially in females and early treatment.

Subcutaneous trastuzumab improves some symptoms and doesn't harm overall quality of life in breast cancer patients.